Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 169   

Articles published

GSK 1,392.00
price chart
Will GlaxoSmithKline plc And AstraZeneca plc Make You Rich In 2015?
A couple of years ago, AstraZeneca was thought to be the one in trouble, thanks to falling profits and a failing drugs pipeline. Now it's the UK pharma golden boy, up 60% over five years.
Mr Market Has Changed His Mind About GlaxoSmithKline plc and AstraZeneca ...  The Motley Fool UK
Related articles »  
Fitch Affirms GlaxoSmithKline PLC at 'A+'; Revises Outlook to Negative
(The following statement was released by the rating agency) LONDON, December 17 (Fitch) Fitch Ratings has affirmed UK-based pharmaceuticals company GlaxoSmithKline PLC's (GSK) Long-term Issuer Default Rating (IDR) and senior unsecured rating at ...
Fitch Revises Outlook on GlaxoSmithKline plc (GSK) to Negative; Sees ...  StreetInsider.com (subscription)
Related articles »  
Should You Buy Shares In GlaxoSmithKline plc, Centrica PLC And BHP Billiton ...
2014 has been a hugely disappointing year for investors in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US). Shares in the pharmaceutical major have been down by as much as 18% during the course of the year and have shown little sign of life in recent ...
Related articles »  
Is GlaxoSmithKline plc Worth �20 Or Less Than A Tenner?
The share price performance of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) over the last ten years has been hugely disappointing.
Pfizer Inc. (NYSE:PFE), GlaxoSmithKline plc (ADR) (NYSE:GSK), Sanofi SA ...  WallStreet.org
Are GlaxoSmithKline's (GSK) Restructuring Efforts Enough For Investors?  Bidness ETC
Related articles »  
3 Stocks That Could Surge By 25%+ Next Year! GlaxoSmithKline plc, Sports ...
Sentiment in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is currently at a low ebb. Evidence of this can be seen in the share price performance of the pharmaceutical major during the course of the last year, with it posting a decline of around 16%.
Related articles »  
Why Shire PLC Has Beaten AstraZeneca plc And GlaxoSmithKline plc In 2014
If you invest in pharmaceuticals, Shire (LSE: SHP) is the one you should have bought this year. It's up 60% in the past 12 months to 4,395p, easily beating the FTSE 100's big two - AstraZeneca (LSE: AZN) (NYSE: AZN.
GlaxoSmithKline plc Earns "Neutral" Rating from JPMorgan Chase ...  Ticker Report
Stock to Watch: GlaxoSmithKline plc (ADR) (NYSE:GSK) Continues to Expand  Stock Markets Daily
Related articles »  
Something Strange Is Going On At GlaxoSmithKline plc�
As part of a drive to rebuild its image after the Chinese bribery scandal, GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) announced sweeping changes to the company's employee compensation plan. In an attempt to prevent employees from bribing their way to ...
If I Could Buy Just One Stock For Christmas, It'd Be GlaxoSmithKline plc
It has to be said, I've never been one to crave the �next big gadget�, or to follow the crowd when it comes to following particular trends.
Related articles »  
3 Reasons GlaxoSmithKline PLC Could Soar in 2015
For many investors, it's been a great year as the S&P 500 has rallied 12% year-to-date. For GlaxoSmithKline (NYSE: GSK ) shareholders, it's been a year to forget with shares dipping by 10% inclusive of its substantial dividend payment. GlaxoSmithKline ...
Related articles »  
Which Company Suits Your Portfolio: AstraZeneca plc Or GlaxoSmithKline plc ?
Pharmaceutical companies make great investments due to their defensive nature and reliable dividend payouts. The FTSE 100′s two pharma giants, AstraZeneca (LSE:AZN) (NYSE: AZN.
Glaxo Is Said Near Announcing Reorganization, Job Cuts  Bloomberg
Related articles »